Evidence map›Paper›PMID 39612031›Full record

Observational studyHepatology international2025

Clinical characteristics and managements of congenital hepatic hemangioma: a cohort study of 211 cases.

Xue Gong, Min Yang, Zixin Zhang, Tong Qiu, Jiangyuan Zhou, Wei Shan, Xuepeng Zhang, Yuru Lan, Pingqian Bao, Zilong Zhou and 10 more

Registry-linked trialAbstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Hepatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03331744 (Clinical Characteristics of Infantile Hemangioma), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03331744 unknown statusnot on this map

Clinical Characteristics of Infantile Hemangioma: a Prospective Study

Typeobservational_patient_registrySponsorWest China HospitalRan2017 to 2025Enrolled1,000ConditionsHemangioma
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Xue Gong *Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.
Min Yang *Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.
Zixin Zhang *Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.
Tong Qiu *Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.
Jiangyuan ZhouDivision of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.
Wei ShanDepartment of Pediatric Surgery, Sichuan Women and Children's Hospital, Chengdu, 610045, China.
Xuepeng ZhangDivision of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.
Yuru LanDivision of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.
Pingqian BaoDepartment of Pediatric Surgery, Leshan Women and Children's Hospital, Leshan, 614099, China.
Zilong ZhouDivision of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.
Congxia YangDivision of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.
Yujia ZhangDivision of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China.
Tianliang LiDepartment of Pediatric Surgery, The First People's Hospital of Zigong, Zigong, 643000, China.
Jing GuoPediatric Surgery Department of the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
Jun GuoDepartment of Pediatrics, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, 621000, China.
Guoyan LuDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
Feiteng KongDepartment of Pediatric Surgery, Chengdu Women and Children's Central Hospital, Chengdu, 610031, China.
Yongbo ZhangDepartment of Pediatric Surgery, Chengdu Women and Children's Central Hospital, Chengdu, 610031, China.
Siyuan ChenPediatric Intensive Care Unit, Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, 610041, China.
Yi JiDivision of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, 610041, China. jijiyuanyuan@163.com.ORCID http://orcid.org/0000-0002-9289-9660

Funding

1·3·5 Project for Disciplines of Excellence-Clinical Research Incubation Project of West China Hospital of Sichuan University 2019HXFH0561·3·5 Project for Disciplines of Excellence-Clinical Research Incubation Project of West China Hospital of Sichuan University 2020HXFH0481·3·5 Project for Disciplines of Excellence-Clinical Research Incubation Project of West China Hospital of Sichuan University 2023HXFH0041·3·5 Project for Disciplines of Excellence-Clinical Research Interdisciplinary Innovation Project of West China Hospital of Sichuan University ZYJC21060Key Project in the Science & Technology Program of Sichuan Province 2022YFS0225Key Project in the Science & Technology Program of Sichuan Province 2022YFS0233Med-X Center for Informatics Funding Project YGJC004National Natural Science Foundation of China 82273556National Natural Science Foundation of China 82473553Project of '0 to 1' of Sichuan University 2022SCUH0033
6 · The paper itself

Abstract

backgroundHepatic hemangiomas can be classified into three morphologic patterns: focal (congenital hepatic hemangiomas [CHHs]), multifocal, and diffuse. We aimed to identify the clinical characteristics of CHH and evaluate the changes in CHH management at our institution over the last 2 decades.

methodsThis was a retrospective cohort study of children diagnosed with CHH who were managed at 8 investigation sites. The primary outcome was changes in CHH size in patients at the last follow-up. The primary exposure of interest was management modality in 2 study periods (2003-2012 versus 2013-2022).

resultsTwo hundred and eleven patients were analyzed. Four different subtypes of CHH were identified. Rapidly involuting CHH patients had complete involution/nearly complete involution, with a median age of 12.0 months. Noninvoluting CHH presented no change in CHH size. Partially involuting CHH patients presented with partial involution and had a stable tumor size at a median age of 16.0 months. Postnatally proliferating CHHs had an initial postnatal increase in CHH lesion size and underwent involution at a median age of 27.0 months. Further analysis revealed that management strategies for CHHs have shifted over time, with the proportion of patients receiving expectant management increasing from 35.4% before 2013 to 77.7% after 2013 (difference, 42.3%; 95% confidence interval 29.3-53.3%). The survival rate of patients with CHH was high (98.6%).

conclusionsWe documented 4 subtypes of CHHs. We found that expectant management strategies have increasingly replaced invasive interventions in patients with CHH over the past 2 decades. RESEARCH REGISTRATION UNIQUE IDENTIFYING NUMBER (UIN): We have already registered at Clinicaltrials.gov. The UIN number is NCT03331744.

Indexed as

HemangiomaLiver NeoplasmsChildChild, PreschoolCohort StudiesFemaleHumansInfantMaleRetrospective StudiesClinical characteristicsComplicationCongenital hepatic hemangiomaManagementSubtype

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.